SCHEMBL25453085

SCHEMBL25453085

CCC1CC(OC(F)(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22210868 1.00 — —
SCHEMBL15113598 0.85 — —
SCHEMBL22435121 0.82 — —
SCHEMBL15381375 0.81 — —
SCHEMBL16549318 0.79 CYP19A1 (0.33) —
SCHEMBL19407060 0.79 CYP19A1 (0.33) —
SCHEMBL19407087 0.79 CYP19A1 (0.33) —
SCHEMBL15784784 0.78 — —
SCHEMBL20722008 0.76 APLNR (0.32) —
SCHEMBL22411998 0.76 APLNR (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023078231-A1 SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS INSILICO MEDICINE IP LIMITED (CN) 2023-05-11 — — WO disclosed
Send feedback